Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Knight

Showing results (591-600 of 614) with videos related to

Pageof 62
Sort By:
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)Hongfang Yang, Patricia F Medeiros, Kaushik Raha, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2021
The National Conference on Health Disparities Student Research ForumMarvella E Ford, Angela M Malek, Erica Martino, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 19, 2013
English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2James R Tysome, Patrick R Axon, Neil P Donnelly, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Blood|June 8, 2017
Enasidenib in mutant <i>IDH2</i> relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Pageof 62

Showing results (591-600 of 614) with videos related to

Sort By:
Pageof 62
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)Hongfang Yang, Patricia F Medeiros, Kaushik Raha, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2021
The National Conference on Health Disparities Student Research ForumMarvella E Ford, Angela M Malek, Erica Martino, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 19, 2013
English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2James R Tysome, Patrick R Axon, Neil P Donnelly, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Blood|June 8, 2017
Enasidenib in mutant <i>IDH2</i> relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Pageof 62